Cleared Special

K083379 - CYNOSURE SMARTLIPO MPX LASER WITH SMARTSENSE C MODULE

K083379 is an FDA 510(k) clearance for CYNOSURE SMARTLIPO MPX LASER WITH SMART..., manufactured by Cynosure, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Special 510(k) pathway after a 28-day FDA review.

K083379 · Cynosure, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2008
Decision
28d
Days
Class 2
Risk

K083379 is an FDA 510(k) clearance for the CYNOSURE SMARTLIPO MPX LASER WITH SMARTSENSE C MODULE. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Cynosure, Inc. (Wesford, US). The FDA issued a Cleared decision on December 12, 2008 after a review of 28 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Cynosure, Inc. devices

FDA 510(k) Submission Details - K083379

510(k) Number K083379 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 14, 2008
Decision Date December 12, 2008
Days to Decision 28 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d faster than avg
Panel avg: 115d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 2022
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K083379.
QUANTA SYSTEM POLYSURGE DIODE LASER FAMILY
K083613 · Quanta System Spa · Dec 2008
EZLASE
K082938 · Biolase Technology, Inc. · Dec 2008
ACUPULSE 30 AND 40 CARBON DIOXIDE LASER SYSTEM
K082809 · Lumenis, Inc. · Dec 2008
15W CERALAS D 1470NM DIODE LASER, MODEL D1470
K082225 · Biolitec, Inc. · Dec 2008
ULTRAWAVE III EX 1320
K083207 · Quanta System Spa · Nov 2008
EZLASE 10W
K083069 · Biolase Technology, Inc. · Nov 2008